A group sequential design allows investigators to sequentially monitor efficacy and safety as part of interim testing in phase III trials. Literature is well developed in the case of continuous and binary outcomes. however. in case of trials with a time-to-event outcome. https://www.camillaers.shop/product-category/scarf/